Founded in 2008, SeamVad is a product based biotechnology company whose breakthrough device enables a qualitatively new approach to vascular anastomosis (surgical connecting / joining between two blood vessels such as in bypass surgery).

The company completed the SeamVad Connector’s proof-of-concept in an animal study is in the midst of developing a fully automatic device (adaptor + connector).

The company submitted a US patent application for the connector and the method and intends to submit additional patent applications during the development process.